RecruitingPhase 1NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Sponsor: Astellas Pharma Inc
Santa Monica, CA · +10 more sites
Lung Cancer clinical trials in Santa Monica, CA
17 recruiting lung cancer studies with a site in Santa Monica, CA.
RecruitingPhase 2 / Phase 3NCT07005102
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Sponsor: AbbVie
Duarte, CA · Irvine, CA · Los Angeles, CA · +15 more sites
RecruitingPhase 1NCT07164313
A Study of ZW251 in Participants With Advanced Solid Tumors
Sponsor: Zymeworks BC Inc.
San Francisco, CA · Santa Monica, CA · +6 more sites
RecruitingPhase 1NCT05877599
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Sponsor: AstraZeneca
Duarte, CA · Los Angeles, CA · Newport Beach, CA · +17 more sites
RecruitingPhase 1NCT07229313
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Sponsor: Kivu Bioscience Inc.
Santa Monica, CA · +1 more sites
RecruitingPhase 3NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Sponsor: Bristol-Myers Squibb
Los Angeles, CA · Sacramento, CA · San Francisco, CA · +53 more sites
RecruitingPhase 1NCT06858813
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Sponsor: AbbVie
Duarte, CA · Irvine, CA · Los Angeles, CA · +7 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
Beverly Hills, CA · Duarte, CA · Orange, CA · +19 more sites
RecruitingPhase 1 / Phase 2NCT06892548
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Sponsor: BioNTech SE
Beverly Hills, CA · Los Angeles, CA · Santa Monica, CA · +14 more sites
RecruitingPhase 1NCT06586515
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor: Eli Lilly and Company
Duarte, CA · Santa Monica, CA · +23 more sites
RecruitingPhase 1NCT06179160
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Sponsor: Incyte Corporation
Palo Alto, CA · Santa Monica, CA · +11 more sites
RecruitingPhase 1 / Phase 2NCT05098132
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Sponsor: Synthekine
Beverly Hills, CA · Fullerton, CA · La Jolla, CA · +30 more sites
RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Anaheim, CA · Fullerton, CA · +103 more sites
RecruitingPhase 1 / Phase 2NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Sponsor: Revolution Medicines, Inc.
Orange, CA · Santa Monica, CA · +19 more sites
RecruitingPhase 1 / Phase 2NCT05785741
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Sacramento, CA · Santa Monica, CA · +13 more sites
RecruitingPhase 1NCT05948865
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Los Angeles, CA · Newport Beach, CA · Santa Monica, CA · +8 more sites
RecruitingPhase 1 / Phase 2NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Los Angeles, CA · +25 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.